Nektar Therapeutics's total assets for Q2 2025 were $207.53M, a decrease of -19.01% from the previous quarter. NKTR total liabilities were $231.75M for the fiscal quarter, a -4.44% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.